1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Shellfish Hypersensitivity: new trials by email Literature Review of Shellfish Hypersensitivity trials Research Report on Shellfish Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Extension Study of ADP101 ADP101 - Food Allergy | Phase 1 / Phase 2 | Terminated | Alladapt Immunotherapeutics, Inc. | 45 | 2022-03-14 | 2024-03-26 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
Egg Hypersensitivity (2) · Food Hypersensitivity (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Milk Hypersensitivity (2) · Nut Hypersensitivity (2) · Peanut Hypersensitivity (2) · Wheat Hypersensitivity (2)
Nut and Peanut Hypersensitivity (2)
Alladapt Immunotherapeutics, Inc. (2)
United States (2)
Mei-Lun Wang, MD (2)